Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001711:Biotransformation / Q000187:drug effects*; D003994:Bucladesine / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003864:Depression, Chemical; D005934:Glucagon / Q000494:pharmacology; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D005958:Glucosephosphates / Q000378:metabolism; D006591:Hexobarbital / Q000378:metabolism; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D000814:Aniline Compounds; D005958:Glucosephosphates; D009249:NADP; D003994:Bucladesine; D005934:Glucagon; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D013806:Theophylline; D000242:Cyclic AMP; D005954:Glucosephosphate Dehydrogenase